ANI Pharmaceuticals, Inc. (BST:BSFA)
Germany · Delayed Price · Currency is EUR 64.50
0.00 (0.00%)
At close: Mar 19, 2026
ANI Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 40.57 | -18.52 | 18.78 | -47.9 | -42.6 | -22.55 |
Depreciation & Amortization | 91.4 | 67.73 | 59.79 | 59.65 | 47.25 | 44.64 |
Stock-Based Compensation | 35.22 | 29.34 | 20.65 | 14.6 | 10.49 | 12.94 |
Other Adjustments | -12.19 | -3.35 | -5.12 | -6.26 | -11.73 | -7.13 |
Change in Receivables | -56.19 | -21.09 | 3.36 | -36.91 | -5.55 | -23.66 |
Changes in Inventories | -10.37 | -21.29 | -5.84 | -23.63 | 3.22 | -2.76 |
Changes in Accounts Payable | 15.57 | 0.48 | 7.55 | 5.04 | 10.17 | -2.29 |
Changes in Accrued Expenses | 71.34 | 30 | 16.81 | 5.16 | -0.48 | 12.97 |
Changes in Income Taxes Payable | -3.15 | -1.42 | 11.99 | -0.16 | -7.57 | 4.88 |
Changes in Other Operating Activities | -2.26 | 2.13 | -9.02 | -0.8 | 0.13 | -1.87 |
Operating Cash Flow | 170.72 | 64.02 | 118.96 | -31.2 | 3.32 | 15.27 |
Operating Cash Flow Growth | 83.77% | -46.19% | - | - | -78.24% | -66.54% |
Capital Expenditures | -14.99 | -16.24 | -8.87 | -8.88 | -2.56 | -6.14 |
Sale of Property, Plant & Equipment | - | 13.51 | - | 0.75 | 2.65 | - |
Purchases of Intangible Assets | -20.41 | -0.72 | -9.64 | -7.58 | -21.08 | -62.19 |
Payments for Business Acquisitions | -8.2 | -401.28 | - | -0.03 | -84.49 | - |
Investing Cash Flow | -43.6 | -404.72 | -18.51 | -15.74 | -105.48 | -68.32 |
Short-Term Debt Issued | - | - | - | - | 24 | 15 |
Short-Term Debt Repaid | - | - | - | - | - | -7.5 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | 24 | 7.5 |
Long-Term Debt Issued | - | 641.25 | - | - | 286.03 | - |
Long-Term Debt Repaid | -12.19 | -296.03 | -3 | -3 | -200.15 | -8.03 |
Net Long-Term Debt Issued (Repaid) | -12.19 | 345.22 | -3 | -3 | 85.88 | -8.03 |
Issuance of Common Stock | 15.27 | 6.49 | 89.55 | 1.46 | 71.65 | 0.62 |
Repurchase of Common Stock | -11.92 | -10.96 | -4.99 | -1.96 | -0.89 | -1.52 |
Net Common Stock Issued (Repurchased) | 3.35 | -4.47 | 84.56 | -0.5 | 70.76 | -0.91 |
Issuance of Preferred Stock | - | - | - | - | 25 | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | 25 | - |
Preferred Share Dividends Paid | -1.56 | -1.63 | -1.63 | -1.63 | -0.19 | - |
Other Financing Activities | -3.88 | -74.18 | -12.5 | - | -10.86 | - |
Financing Cash Flow | -10.22 | 264.95 | 67.44 | -5.13 | 194.6 | -1.44 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.73 | -0.47 | - | - | - | - |
Net Cash Flow | 117.63 | -76.23 | 167.89 | -52.07 | 92.43 | -54.49 |
Free Cash Flow | 155.73 | 47.78 | 110.09 | -40.08 | 0.77 | 9.13 |
Free Cash Flow Growth | 225.93% | -56.60% | - | - | -91.62% | -76.58% |
FCF Margin | 18.83% | 7.78% | 22.61% | -12.67% | 0.35% | 4.38% |
Free Cash Flow Per Share | 7.80 | 2.47 | 6.05 | -2.46 | - | 0.76 |
Levered Free Cash Flow | 124.69 | 388.09 | 88.2 | -14.51 | 117.44 | 26.36 |
Unlevered Free Cash Flow | 205.3 | 61.88 | 116.81 | 9.42 | 19.92 | 35.54 |
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.